Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Shares Outstanding (2016 - 2025)

Vanda Pharmaceuticals' Shares Outstanding history spans 6 years, with the latest figure at $41.8 million for Q1 2015.

  • For Q1 2015, Shares Outstanding rose 23.38% year-over-year to $41.8 million; the TTM value through Mar 2015 reached $41.8 million, up 23.38%, while the annual FY2014 figure was $41.5 million, 24.44% up from the prior year.
  • Shares Outstanding for Q1 2015 was $41.8 million at Vanda Pharmaceuticals, up from $41.5 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $28.2 billion in Q1 2012 and bottomed at $28.1 million in Q2 2011.
  • The 5-year median for Shares Outstanding is $30.8 million (2013), against an average of $1.8 billion.
  • The largest annual shift saw Shares Outstanding plummeted 99.9% in 2013 before it increased 24.44% in 2014.
  • A 5-year view of Shares Outstanding shows it stood at $28.1 million in 2011, then grew by 0.44% to $28.2 million in 2012, then rose by 18.05% to $33.3 million in 2013, then grew by 24.44% to $41.5 million in 2014, then increased by 0.74% to $41.8 million in 2015.
  • Per Business Quant, the three most recent readings for VNDA's Shares Outstanding are $41.8 million (Q1 2015), $41.5 million (Q4 2014), and $33.9 million (Q3 2014).